Acute Myelogenous Leukemia (AML) Due to Therapy
1 clinical trials · Condition
◉ Watch Acute Myelogenous Leukemia (AML) Due to Therapy
| Record | Firm | Date |
|---|---|---|
| CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia (NCT04231851) | University of California, Irvine | 2020-02-19 |
Track Acute Myelogenous Leukemia (AML) Due to Therapy automatically
Every clearance here is in the API, with alerts when new ones post.